Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pro Dex (PDEX) Gains from Sales and Divestitures (2013 - 2016)

Pro Dex recorded quarterly Gains from Sales and Divestitures of $5000.0 in Q2 2016, little changed quarter-over-quarter from $5000.0 in Q1 2016, and down 24.99% year-over-year from $6666.0 in Q3 2015.

Pro Dex's Gains from Sales and Divestitures history runs 4 years deep, the most recent figure standing at $5000.0 for Q2 2016.

  • In Q2 2016, Gains from Sales and Divestitures fell 24.99% year-over-year to $5000.0; the TTM figure through Jun 2016 stood at $5000.0 (down 24.99% YoY), while the FY2016 annual figure was $5000.0, down 24.99% from the prior year.
  • Gains from Sales and Divestitures came in at $5000.0 for Q2 2016 at Pro Dex, roughly flat from $5000.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $9166.0 in Q2 2014 to a low of -$9166.0 in Q3 2013.
  • A 4-year average of $2361.2 and a median of $5000.0 in 2015 frame the typical range for Gains from Sales and Divestitures.
  • Across the five-year window, Gains from Sales and Divestitures jumped 172.74% in 2014 and declined 27.27% in 2015, its largest moves.
  • Pro Dex's Gains from Sales and Divestitures stood at -$9166.0 in 2013, then surged by 172.74% to $6667.0 in 2014, then fell by 25.0% to $5000.0 in 2015, then changed by 0.0% to $5000.0 in 2016.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods registered $5000.0, $5000.0, and $5000.0 for Q2 2016, Q1 2016, and Q4 2015 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Pro Dex 201.21 Mn 193.60 Mn 6.13 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2016 5,000.00
Jun 30, 2016 5,000.00
Mar 31, 2016 5,000.00
Mar 31, 2016 5,000.00
Dec 31, 2015 5,000.00
Dec 31, 2015 5,000.00
Sep 30, 2015 5,000.00
Sep 30, 2015 5,000.00
Jun 30, 2015 6,666.00
Jun 30, 2015 6,666.00
Mar 31, 2015 6,667.00
Mar 31, 2015 6,667.00
Dec 31, 2014 6,667.00
Dec 31, 2014 6,667.00
Sep 30, 2014 6,667.00
Sep 30, 2014 6,667.00
Jun 30, 2014 9,166.00
Jun 30, 2014 9,166.00
Mar 31, 2014 -9,166.00
Mar 31, 2014 -9,166.00
Dec 31, 2013 -9,166.00
Dec 31, 2013 -9,166.00
Sep 30, 2013 -9,166.00
Sep 30, 2013 -9,166.00